药物对比
Teplizumab vs Insulin Detemir
Teplizumab（Tzield）可延缓1型糖尿病发病，insulin detemir（Levemir）是一种长效胰岛素。比较CD3调节与1型糖尿病中的血糖调节。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating immunotherapy to delay T1D onset versus basal insulin needs in later disease stages.
结论
Teplizumab and insulin detemir address sequential needs in type 1 diabetes and are not interchangeable.
全部药物对比